Nath Bio-Genes

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
142.45
-3.4 (-2.33%)
BSENSE

Dec 05

BSE+NSE Vol: 59.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'13
Mar'12
No of Months
12
12
12
12
12
12
Operating Income
364.00
332.00
301.00
278.00
137.00
123.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
364.00
332.00
301.00
278.00
137.00
123.00
Expenditure (Ex Depriciation)
Stock Adjustments
-102.00
-21.00
11.00
4.00
-10.00
-2.00
Raw Materials Consumed
12.00
12.00
5.00
3.00
8.00
6.00
Power & Fuel Cost
1.00
1.00
1.00
1.00
0.00
0.00
Employee Cost
32.00
28.00
23.00
24.00
10.00
9.00
Operating Expenses
214.00
121.00
95.00
114.00
65.00
55.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
4.00
4.00
Selling and Distribution Expenses
119.00
107.00
85.00
64.00
37.00
34.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
4.00
1.00
1.00
1.00
1.00
2.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
314.00
282.00
252.00
241.00
117.00
109.00
Operating Profit (PBDIT) excl Other Income
49.00
49.00
48.00
37.00
19.00
14.00
Other Income
4.00
0.00
0.00
1.00
0.00
0.00
Operating Profit (PBDIT)
54.00
50.00
49.00
39.00
20.00
15.00
Interest
10.00
9.00
10.00
10.00
3.00
1.00
Profit before Depriciation and Tax
43.00
41.00
39.00
28.00
16.00
13.00
Depreciation
3.00
3.00
3.00
3.00
4.00
4.00
Profit Before Taxation & Exceptional Items
40.00
38.00
36.00
25.00
12.00
9.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
40.00
41.00
36.00
-63.00
12.00
9.00
Provision for Tax
1.00
1.00
1.00
3.00
0.00
0.00
Profit After Tax
38.00
39.00
35.00
-67.00
11.00
9.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
441.00
405.00
374.00
445.00
14.00
4.00
Profit Available for appropriations
480.00
445.00
409.00
378.00
25.00
14.00
Appropriations
480.00
445.00
409.00
378.00
25.00
14.00
Equity Dividend (%)
20.00%
20.00%
20.00%
20.00%
0.00%
0.00%
Earnings Per Share
20.14
21.34
18.43
-35.55
7.34
5.75
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.71% vs 10.37% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 0.02% vs 2.29% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 15.69% vs -9.88% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -2.57% vs 13.16% in Mar 2024

Compare Profit and Loss Results of Nath Bio-Genes
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
364.00
0
364.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
364.00
0
364.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-102.00
0
-102.00
0%
Raw Materials Consumed
12.00
0
12.00
0%
Power & Fuel Cost
1.00
0
1.00
0%
Employee Cost
32.00
0
32.00
0%
Operating Expenses
214.00
0
214.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
119.00
0
119.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
4.00
0
4.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
314.00
0
314.00
0%
Operating Profit (PBDIT) excl Other Income
49.00
0.00
49.00
0%
Other Income
4.00
0
4.00
0%
Operating Profit (PBDIT)
54.00
0
54.00
0%
Interest
10.00
0
10.00
0%
Profit before Depriciation and Tax
43.00
0
43.00
0%
Depreciation
3.00
0
3.00
0%
Profit Before Taxation & Exceptional Items
40.00
0
40.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
40.00
0
40.00
0%
Provision for Tax
1.00
0
1.00
0%
Profit After Tax
38.00
0
38.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
441.00
0
441.00
0%
Profit Available for appropriations
480.00
0
480.00
0%
Appropriations
480.00
0
480.00
0%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
20.14
0
20.14
0%
Profit And Loss - Net Sales
Net Sales 364.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.71% vs 10.37% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.02% vs 2.29% in Mar 2024

Profit And Loss - Interest
Interest 10.65 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.69% vs -9.88% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 38.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.57% vs 13.16% in Mar 2024